Search details
1.
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Br J Haematol
; 202(1): 40-47, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36971061
2.
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Ann Hematol
; 102(4): 811-817, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36847805
3.
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group.
Hematol Oncol
; 38(4): 509-516, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32400885
4.
Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene.
Epigenetics
; 17(12): 1628-1635, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35333703
Results
1 -
4
de 4
1
Next >
>>